{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:25:21Z","timestamp":1794486321239,"version":"4.9.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001506","name":"Ministry of Science and Innovation, New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jare.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T13:21:12Z","timestamp":1613568072000},"page":"141-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach"],"prefix":"10.1016","volume":"33","author":[{"given":"Most. Nazma","family":"Parvin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abdul","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikder Nahidul Islam","family":"Rabbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Md. Abdullah","family":"Al-Mamun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Saiful","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-5319","authenticated-orcid":false,"given":"Mohammad Safiqul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jare.2021.02.001_b0005","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4103\/1319-2442.121288","article-title":"Pattern of glomerular disease in the Saudi population: A single-center, five-year retrospective study","volume":"24","author":"Nawaz","year":"2013","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0010","article-title":"Management of steroid resistant nephrotic syndrome","volume":"46","author":"Bagga","year":"2009","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.jare.2021.02.001_b0015","series-title":"Brenner & Rector's The Kidney","first-page":"297","article-title":"Nephrotic Syndrome","author":"Levine","year":"2003"},{"issue":"3","key":"10.1016\/j.jare.2021.02.001_b0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1542\/pir.30.3.94","article-title":"The nephrotic syndrome","volume":"30","author":"Gordillo","year":"2009","journal-title":"Pediatr Rev"},{"issue":"3","key":"10.1016\/j.jare.2021.02.001_b0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-018-3929-z","article-title":"Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome","volume":"34","author":"Schijvens","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jare.2021.02.001_b0030","series-title":"Pediatric Nephrology","first-page":"1643","article-title":"Pediatric nephrology around the world","author":"Salusky","year":"2009"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3329\/bjch.v37i2.17268","article-title":"An update of Management of idiopathic nephrotic syndrome: a review article","volume":"37","author":"Rahman","year":"2013","journal-title":"Bangladesh J Child Health"},{"key":"10.1016\/j.jare.2021.02.001_b0040","series-title":"Pediatric nephrology","first-page":"667","article-title":"Idiopathic Nephrotic Syndrome in Children","author":"Niaudet","year":"2009"},{"key":"10.1016\/j.jare.2021.02.001_b0045","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fped.2019.00339","article-title":"Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome","volume":"7","author":"Goonewardene","year":"2019","journal-title":"Front Pediatr"},{"issue":"11","key":"10.1016\/j.jare.2021.02.001_b0050","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/adc.60.11.1014","article-title":"Steroid responsive nephrotic syndrome is more common in Asians","volume":"60","author":"Sharples","year":"1985","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jare.2021.02.001_b0055","unstructured":"Hossain MM, Management of minimal change nephrotic syndrome in children with frequent relapse. In: Rashid Harun Ur, editor. South Asian renal disease, proceeding of the 2nd International Conference of nephrology Urology and transplantation society of SAARC countries, Feb, 18-20, 1997, Bangladesh: 9-20."},{"key":"10.1016\/j.jare.2021.02.001_b0060","first-page":"389","article-title":"Pediatric nephrotic syndrome: from the simple to the complex","volume":"vol. 29, no. 4","author":"Lane","year":"2009"},{"issue":"12","key":"10.1016\/j.jare.2021.02.001_b0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S2352-4642(18)30283-9","article-title":"Management of steroid-resistant nephrotic syndrome in children and adolescents","volume":"2","author":"Tullus","year":"2018","journal-title":"Lancet Child Adolescent Health"},{"key":"10.1016\/j.jare.2021.02.001_b0070","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10165.1","article-title":"Recent advances in understanding and treating nephrotic syndrome","volume":"6","author":"Bierzynska","year":"2017","journal-title":"F1000 Res"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gene.2013.08.045","article-title":"Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids","volume":"530","author":"Youssef","year":"2013","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.jare.2021.02.001_b0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3345\/kjp.2017.60.3.55","article-title":"Genetics of hereditary nephrotic syndrome: a clinical review","volume":"60","author":"Ha","year":"2017","journal-title":"Korean J Pediatr"},{"issue":"12","key":"10.1016\/j.jare.2021.02.001_b0085","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1093\/ndt\/gfr150","article-title":"MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children","volume":"26","author":"Jafar","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0021-9258(19)75806-2","article-title":"The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation","volume":"262","author":"Ueda","year":"1987","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.0.1750251","article-title":"The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone","volume":"175","author":"Karssen","year":"2002","journal-title":"J Endocrinol"},{"issue":"12","key":"10.1016\/j.jare.2021.02.001_b0100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00431-006-0177-1","article-title":"Expression of P-glycoprotein in lymphocytes of children with nephrotic syndrome treated with glucocorticoids","volume":"165","author":"Wasilewska","year":"2006","journal-title":"Eur J Pediatr"},{"issue":"4","key":"10.1016\/j.jare.2021.02.001_b0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/phgs.4.4.397.22747","article-title":"Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs","volume":"4","author":"Sakaeda","year":"2003","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jare.2021.02.001_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1417456","article-title":"Single nucleotide polymorphisms in pediatric idiopathic nephrotic syndrome","volume":"2016","author":"Suvanto","year":"2016","journal-title":"Int J Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00467-006-0275-3","article-title":"MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children","volume":"22","author":"Wasilewska","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.jare.2021.02.001_b0120","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00467-012-2182-0","article-title":"Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome","volume":"27","author":"Chiou","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/09674845.2016.1220707","article-title":"ABCB1 polymorphisms and steroid treatment in children with idiopathic nephrotic syndrome","volume":"74","author":"Safan","year":"2017","journal-title":"Br J Biomed Sci"},{"issue":"11","key":"10.1016\/j.jare.2021.02.001_b0130","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00467-011-1903-0","article-title":"Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome","volume":"26","author":"Choi","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1016\/j.jare.2021.02.001_b0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1089\/gtmb.2015.0077","article-title":"Association of ACE and MDR1 gene polymorphisms with steroid resistance in children with idiopathic nephrotic syndrome","volume":"19","author":"Dhandapani","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.jare.2021.02.001_b0140","first-page":"59","article-title":"MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results","volume":"21","author":"Cizmarikova","year":"2015","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"24","key":"10.1016\/j.jare.2021.02.001_b0145","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007191","article-title":"A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: susceptibility and steroid responsiveness","volume":"96","author":"Han","year":"2017","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1442-200X.2008.02541.x","article-title":"Multiple drug-resistant gene 1 in children with steroid-sensitive nephrotic syndrome","volume":"50","author":"Funaki","year":"2008","journal-title":"Pediatr Int"},{"issue":"7","key":"10.1016\/j.jare.2021.02.001_b0155","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1101\/gr.1965304","article-title":"Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene","volume":"14","author":"Soranzo","year":"2004","journal-title":"Genome Res"},{"issue":"16","key":"10.1016\/j.jare.2021.02.001_b0160","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids-new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.jare.2021.02.001_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2008.10.001","article-title":"Molecular mechanisms regulating glucocorticoid sensitivity and resistance","volume":"300","author":"Gross","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.jare.2021.02.001_b0170","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00467-003-1177-2","article-title":"Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome","volume":"18","author":"Wasilewska","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jare.2021.02.001_b0175","first-page":"917","article-title":"Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus","volume":"83","author":"Huizenga","year":"1998","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jare.2021.02.001_b0180","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1210\/jc.2003-031235","article-title":"Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype","volume":"89","author":"Stevens","year":"2004","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbrc.2006.07.097","article-title":"Genetic variations of the NR3C1 gene in children with sporadic nephrotic syndrome","volume":"348","author":"Ye","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.jare.2021.02.001_b0190","first-page":"2056","article-title":"Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo","volume":"60","author":"Hillmann","year":"2000","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"10.1016\/j.jare.2021.02.001_b0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0009-8981(01)00661-1","article-title":"The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis","volume":"313","author":"Jiang","year":"2001","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.jare.2021.02.001_b0200","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1210\/jcem.87.4.8379","article-title":"Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene","volume":"87","author":"Mendonca","year":"2002","journal-title":"J Clin Endocrinol Metabol"},{"issue":"9","key":"10.1016\/j.jare.2021.02.001_b0205","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","article-title":"The genetic determinants of the CYP3A5 polymorphism","volume":"11","author":"Hustert","year":"2001","journal-title":"Pharmacogenet Genom"},{"issue":"8","key":"10.1016\/j.jare.2021.02.001_b0210","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.TP.0000090753.99170.89","article-title":"Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients","volume":"76","author":"Thervet","year":"2003","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jare.2021.02.001_b0215","first-page":"1233","article-title":"MDR-1 and CYP3A5 Polymorphisms in Pediatric Idiopathic Nephrotic Syndrome: Impact on Susceptibility and Response to Steroids (Preliminary Results)","volume":"63","author":"Moussa","year":"2017","journal-title":"Clin Laborat"},{"key":"10.1016\/j.jare.2021.02.001_b0220","unstructured":"World Medical Association. Helsinki Declaration: Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964 and Latest Amended by 64th WMA General Assembly, Fortaleza, Brazil, October 2013. (2013). Available from: https:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/."},{"key":"10.1016\/j.jare.2021.02.001_b0225","doi-asserted-by":"crossref","unstructured":"International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981;98:561\u20134.","DOI":"10.1016\/S0022-3476(81)80760-3"},{"issue":"8","key":"10.1016\/j.jare.2021.02.001_b0230","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3345\/kjp.2011.54.8.322","article-title":"Complications of nephrotic syndrome","volume":"54","author":"Park","year":"2011","journal-title":"Kor J Pediatr"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0235","first-page":"139","article-title":"Work Group. KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"Kdigo","year":"2012","journal-title":"Kidney Int Supplem"},{"key":"10.1016\/j.jare.2021.02.001_b0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cca.2012.11.011","article-title":"Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population","volume":"416","author":"Islam","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2125.2003.01820.x","article-title":"Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates","volume":"56","author":"Balram","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0250","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s13277-013-1230-0","article-title":"Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population","volume":"35","author":"Islam","year":"2014","journal-title":"Tumor Biol"},{"issue":"11","key":"10.1016\/j.jare.2021.02.001_b0265","first-page":"1","article-title":"Steroid resistant nephrotic syndrome in children: clinical presentation, renal histology, complications, treatment and outcome at Bangabandhu Sheikh Mujib Medical University, Dhaka","volume":"4","author":"Roy","year":"2014","journal-title":"Bangladesh IOSR J Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3329\/nimcj.v8i1.32389","article-title":"Renal Histopathology in Childhood Nephrotic Syndrome at National Institute of Kidney Diseases and Urology, Dhaka, Bangladesh an experience of one decade","volume":"8","author":"Alam","year":"2016","journal-title":"Northern Int Med College J"},{"issue":"9","key":"10.1016\/j.jare.2021.02.001_b0275","first-page":"62","article-title":"Correlation between Serum Prednisolone and Serum Albumin level in Childhood with Nephrotic Syndrome: A study in tertiary care hospital in Bangladesh","volume":"17","author":"Siddique","year":"2018","journal-title":"IOSR J Dent Med Sci"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3329\/fmcj.v7i1.10292","article-title":"Risk factor for relapse in childhood nephrotic syndrome-a hospital based retrospective study","volume":"7","author":"Sarker","year":"2012","journal-title":"Faridpur Med College J"},{"issue":"4","key":"10.1016\/j.jare.2021.02.001_b0285","first-page":"251","article-title":"Mesangial proliferative glomerulonephritis in children","volume":"3","author":"Uszycka-Karcz","year":"1982","journal-title":"Int J Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.jare.2021.02.001_b0290","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00580-018-2719-0","article-title":"ABCB1 gene polymorphism in nephrotic syndrome","volume":"27","author":"Mohammed","year":"2018","journal-title":"Comp Clin Pathol"},{"issue":"20","key":"10.1016\/j.jare.2021.02.001_b0295","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1158\/0008-5472.CAN-07-2377","article-title":"Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer","volume":"67","author":"Sauna","year":"2007","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0300","doi-asserted-by":"crossref","first-page":"418","DOI":"10.22159\/ajpcr.2017.v10i2.16067","article-title":"Identification of Functional Single Nucleotide Polymorphisms of Multidrug Resistance Gene-1 Among Nephrotic Syndrome Children in South India","volume":"10","author":"Ganesan","year":"2017","journal-title":"Asian J Pharm Clin Res"},{"issue":"3","key":"10.1016\/j.jare.2021.02.001_b0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2478\/raon-2018-0034","article-title":"Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia","volume":"52","author":"Gasic","year":"2018","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0310","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/pgs-2017-0084","article-title":"NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome","volume":"19","author":"Liu","year":"2018","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.jare.2021.02.001_b0315","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2007.02887.x","article-title":"Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis","volume":"67","author":"Donn","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0320","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI116963","article-title":"Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy","volume":"93","author":"Sher","year":"1994","journal-title":"J Clin Investig"},{"issue":"10","key":"10.1016\/j.jare.2021.02.001_b0325","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1210\/jc.2005-0646","article-title":"Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression","volume":"90","author":"Russcher","year":"2005","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0330","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.clim.2009.07.006","article-title":"The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients","volume":"133","author":"Fujishima","year":"2009","journal-title":"Clin Immunol"},{"issue":"11","key":"10.1016\/j.jare.2021.02.001_b0335","first-page":"725","article-title":"The expression of glucocorticoid receptor beta messenger RNA in peripheral white blood cells of hormone-resistant nephrotic syndrome patients","volume":"40","author":"Liu","year":"2001","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"5","key":"10.1016\/j.jare.2021.02.001_b0340","first-page":"629","article-title":"A new link between steroid resistance, glucocorticoid receptor and nuclear factor kappa B p65 in idiopathic nephrotic syndrome","volume":"30","author":"Szilagyi","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0345","doi-asserted-by":"crossref","first-page":"11890","DOI":"10.1038\/s41598-017-12255-0","article-title":"Correlation between polymorphisms of the NR3C1 gene and glucocorticoid effectiveness in patients with pemphigus vulgaris","volume":"7","author":"Fang","year":"2017","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10.1016\/j.jare.2021.02.001_b0350","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lfs.2012.06.010","article-title":"NR3C1 gene polymorphism for genetic susceptibility to infantile spasms in a Chinese population","volume":"91","author":"Yang","year":"2012","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0355","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40101-019-0194-1","article-title":"NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han Chinese","volume":"38","author":"Yang","year":"2019","journal-title":"J Physiol Anthropol"},{"issue":"16","key":"10.1016\/j.jare.2021.02.001_b0360","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1158\/1078-0432.CCR-04-2097","article-title":"Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia","volume":"11","author":"Tissing","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.jare.2021.02.001_b0365","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3345\/kjp.2009.52.11.1260","article-title":"Polymorphisms of the NR3C1 gene in Korean children with nephrotic syndrome","volume":"52","author":"Cho","year":"2009","journal-title":"Kor J Pediatr"},{"issue":"4","key":"10.1016\/j.jare.2021.02.001_b0370","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.transproceed.2005.02.073","article-title":"Impact of CYP3A5 and MDR1 (ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients","volume":"37","author":"Tada","year":"2005","journal-title":"Transpl Proc"},{"issue":"5","key":"10.1016\/j.jare.2021.02.001_b0375","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1399-3046.2011.01513.x","article-title":"Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: age dependency and pharmacological interaction with steroids","volume":"15","author":"Ferraris","year":"2011","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0380","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bcp.12345","article-title":"Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients","volume":"78","author":"Cusinato","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2021.02.001_b0385","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40360-018-0202-9","article-title":"Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome","volume":"19","author":"Li","year":"2018","journal-title":"BMC Pharmacol Toxicol"},{"issue":"10","key":"10.1016\/j.jare.2021.02.001_b0390","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00008571-200310000-00004","article-title":"The CYP3A4* 1B allele increases risk for small cell lung cancer: effect of gender and smoking dose","volume":"13","author":"Dally","year":"2003","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"10.1016\/j.jare.2021.02.001_b0395","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3329\/dujps.v14i2.28508","article-title":"Prostate Cancer Risk in Relation to CYP3A4 and CYP3A5 Genotypes in the Bangladeshi Population","volume":"14","author":"Bellah","year":"2015","journal-title":"Dhaka Univer J Pharmaceut Sci"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:52:32Z","timestamp":1761857552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123221000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":77,"alternative-id":["S2090123221000278"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2021.02.001","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}